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RAG2:GFP Knockin Mice Reveal Novel Aspects
of RAG2 Expression in Primary
and Peripheral Lymphoid Tissues
In developing thymocytes, RAG1 and RAG2 are ex-
pressed first in the CD42CD82 double-negative (DN)
compartment, which can be further subdivided based on
the differential expression of CD44 and CD25 (Rodewald
and Fehling, 1998). Past studies indicated that RAG ex-
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arrangement leads to expression of a pre-TCR com-Harvard Medical School
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as cells progress to the CD442CD252 stage (FehlingDuke University Medical School
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arrangement is initiated as ab lineage cells differentiate
into CD41CD81 double-positive (DP) thymocytes and
express high RAG levels (Guy-Grand et al., 1992; WilsonSummary
et al., 1994). RAG expression is downregulated a second
time during the maturation of DP cells into CD41CD82 orWe generated mice in which a functional RAG2:GFP
CD42CD81 single-positive (SP) thymocytes, a processfusion gene is knocked in to the endogenous RAG2
that can be mimicked in vitro by TCR cross-linkinglocus. In bone marrow and thymus, RAG2:GFP expres-
(Turka et al., 1991). gd lineage thymocytes also can besion occurs in appropriate stages of developing B and
divided into immature and mature subsets based onT cells as well as in immature bone marrow IgM1 B
expression of heat-stable antigen (HSA). Analogous tocells. RAG2:GFP also is expressed in IgD1 B cells fol-
DP ab lineage thymocytes, HSAhi gd thymocytes werelowing cross-linking of IgM on immature IgM1IgD1 B
reported to express RAG1 and RAG2 and to downregu-cells generated in vitro. RAG2:GFP expression is unde-
late these genes in response to TCR cross-linking (Tat-tectable in most immature splenic B cells; however,
sumi et al., 1993).in young RAG2:GFP mice, there are substantial num-
In developing bone marrow (BM), RAG1 and RAG2bers of splenic RAG2:GFP1 cells that mostly resemble
expression is first detected in pro±B cells undergoingpre±B cells. The latter population decreases in size
sequential Ig heavy (H) chain D to JH and VH to DJHwith age but reappears following immunization of
rearrangements (Willerford et al., 1996). Functional VDJHolder RAG2:GFP mice. We discuss the implications of
rearrangement leads to expression of a pre±B cell recep-these findings for current models of receptor assembly
tor composed of mH chain plus the V-pre-B and l5and diversification.
surrogate light chains, cellular expansion, and downreg-
ulation of RAG gene expression (Grawunder et al., 1995).
Introduction RAG downregulation may prevent further VH to DJH re-
arrangements on the second allele and thereby facilitate
Immunoglobulin (Ig) and T cell receptor (TCR) variable enforcement of IgH chain allelic exclusion. Subse-
region genes are assembled in developing lymphocytes quently, RAG genes are upregulated in later-stage pre±B
from germline variable (V), diversity (D), and joining (J) cells, coincident with the onset of Ig light (L) chain gene
gene segments (Willerford et al., 1996). This V(D)J re- rearrangement (Grawunder et al., 1995). Functional L
combination reaction is effected by the same set of chain expression leads to surface immunoglobulin M
proteins in B and T lineage cells. The critical lymphocyte- (sIgM) deposition and developmental progression to the
specific components of the reaction are the recombina- immature B cell stage. In this context, sIgM cross-linking
tion-activating proteins RAG1 and RAG2 that initiate has been shown to downregulate V(D)J recombinase
V(D)J recombination by introducing double-stranded expression in various types of B cells (Ma et al., 1992;
DNA breaks at the borders of Ig and TCR V, D, and J Hertz et al., 1998; Meffre et al., 1998). However, at least
coding segments and adjacent recombination signal some immature BM B cells express RAG genes (Ma et
(RS) sequences (Gellert, 1997). Following cleavage by al., 1992; Li et al., 1993; Grawunder et al., 1995), consis-
the RAG proteins, the liberated coding (and RS) ends tent with a capacity for receptor editingÐa process
are rejoined by a set of generally expressed proteins whereby antigen receptor triggering by avid self-anti-
that carry out a nonhomologous end-joining reaction gens leads to developmental arrest, secondary L chain
(Smider and Chu, 1997). The initiation of V(D)J recombi- gene rearrangements, and specificity changes (Hartley
nation is tightly regulated via differential accessibility et al., 1993; Tiegs et al., 1993; Radic and Zouali, 1996;
of antigen receptor loci and the lymphocyte-specific Chen et al., 1997; Pelanda et al., 1997).
expression of RAG1 and RAG2 (Sleckman et al., 1996). Immature splenic B cells that have recently emigrated
from the BM can be distinguished from their mature
counterparts by lower B220 and IgD levels, higher HSA³ To whom correspondence should be addressed (e-mail: alt@
rascal.med.harvard.edu). and IgM levels, and continued expression of the pB130±
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Figure 1. Generation of RAG2:GFP Knockin
ES Cells and Mice
(A) A targeting vector was designed to re-
place the endogenous RAG2 gene with the
RAG2:GFP fusion gene (see text for details),
employing regions 59 and 39 of RAG2 to direct
homologous recombination and a loxP-
flanked PGK-neor gene. The endogenous
RAG2 allele is depicted with the RAG2:GFP
knockin construct and a RAG2:GFP allele, fol-
lowing targeting and Cre-mediated deletion
of the PGK-neor gene. Also indicated are the
RAG2 39 UTR (hatched boxes), loxP sites
(starred boxes), and probes used for analysis
of 59 and 39 homologous recombination
(shaded boxes).
(B) Southern blot with the 39 probe on EcoRI-
digested DNA isolated from wild-type ES cells
(1/1), ES cells targeted with the RAG2:GFP
knockin construct [1/GFP (Neo1)], and the lat-
ter cells following Cre-mediated deletion of the
PGK-neor gene [1/GFP (NeoD)].
(C) Southern blot with the 39 probe on EcoRI-
digested tail DNA of offspring from a mating
of heterozygous RAG2:GFP knockin mice
(RAG21/GFP 3 RAG21/GFP).
140 marker (Allman et al., 1992, 1993; Rolink et al., 1998). splenic pre±B cells within B cell follicles (Young et al.,
1997). Similarly, activated Ras transgene expression inThese ªtransitionalº B cells may also be distinguished
from the immature BM B cells by their response to anti- IgH chain±deficient B lineage cells also leads to accumu-
lation of RAG-expressing, sIgM2 splenic B lineage cellsgen receptor cross-linking. While immature BM B cells
respond to BCR ligation by undergoing secondary L with rearranged L chain genes (Shaw et al., 1999). While
the physiological significance of such mutant splenic Bchain rearrangements, transitional B cells are highly sen-
sitive to antigen-induced apoptosis in vivo (Carsetti et lineage cells is speculative, these studies demonstrate that
pre-B-like cells are capable of leaving the BM in significantal., 1995). In addition, in vitro studies have shown that
IgMlo immature cells respond to BCR ligation by upregu- numbers and taking up residence in the spleen.
To examine further the developmental stages andlating RAG genes and editing their receptors, while IgMhi
transitional cells respond to the same treatment by un- physiological factors that lead to modulation of RAG
expression, we have generated novel reporter mice indergoing apoptosis (Melamed et al., 1998). This differen-
tial response of immature and transitional B cells to which a RAG2:GFP fusion gene replaces the endoge-
nous RAG2 coding exon.BCR cross-linking has been argued to result from the
protective influence of the BM microenvironment (San-
del and Monroe, 1999). Collectively, these studies sug- Results
gest that receptor editing may be the major tolerance
mechanism of newly formed BM B cells, but as B cells Generation of RAG2:GFP Knockin Mice
The EGFP gene (Clontech) was fused in-frame to the finalmature and enter the spleen, they lose the capacity to edit
and instead undergo apoptosis upon binding self-antigen. codon of the RAG2 gene. This fusion maintains the com-
plete RAG2 coding sequence, including the sequencesThe relative level of RAG gene expression in transi-
tional splenic B cells has not been carefully examined. that encode the phosphorylation site that directs cell cy-
cle±specific degradation of the RAG2 protein (Li et al.,However, the finding of RAG1 and RAG2 expression in
splenic B cells stimulated in vitro with LPS1IL-4 and in 1996). The 39 untranslated region (UTR) of RAG2 was
also retained 39 of the fusion gene to provide polyadenyl-germinal center (GC) B cells of immunized mice sug-
gested that at least some splenic B cells can be induced ation signals and to allow for normal regulation. Thus,
our reporter was designed to preserve as closely asto reexpress or upregulate these genes (Han et al., 1996,
1997a; Hikida et al., 1996; Papavasiliou et al., 1997). possible the endogenous regulation of RAG2 at both the
transcriptional and posttranscriptional levels, includingRAG-expressing GC cells also can undergo secondary
L chain gene rearrangements, possibly as a means of appropriate degradation of the reporter protein.
A targeting construct was engineered to replace theediting low-affinity receptors or receptors debilitated by
somatic mutation (Kelsoe, 1999). Such GC cells could, endogenous RAG2 gene with the RAG2:GFP fusion
gene, using genomic sequences 59 and 39 of the RAG2in theory, represent pre±B/immature B cells in the
spleen, as they share a number of characteristics with coding exon to direct homologous recombination and
a neomycin resistance gene (PGK-neor) flanked by loxPpre±B cells, including surrogate L chain gene expres-
sion, low B220 levels, and high HSA levels (Han et al., sites for selection (Figure 1A). Targeted replacement of
RAG2 with the RAG2:GFP fusion gene and the loxP-1997b). A precedent for the existence of immature RAG-
expressing B cells in the spleen is provided by studies flanked PGK-neor gene was carried out in TC1 (129SvEv)
embryonic stem (ES) cells (Figure 1B). We subsequentlyof Igm HCTG/BCL-2TG RAG22/2 mice, which accumulate
RAG2 Expression in RAG2:GFP Knockin Mice
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Figure 2. Expression of RAG2:GFP in Developing Thymocytes
FACS analysis was performed on thymocytes isolated from RAG21/1 (WT) and RAG2GFP/GFP (RAG2:GFP) mice after staining for the indicated
cell surface markers. A representative FACS plot is shown for each set of markers, as there were no significant differences in phenotype
between WT and RAG2:GFP thymocytes. For each of the gated populations (depicted by schematics), histograms for green fluorescence
were generated. WT histograms (shaded) were overlayed with RAG2:GFP histograms (open); percentages of cells out of total live lymphocytes
are shown for each population (top, WT; bottom, RAG2:GFP).
(A) Thymocytes were stained with phycoerythrin-conjugated (PE) anti-CD25, cychrome-conjugated (CyC) anti-CD44, and a cocktail of biotin-
conjugated (bi) antibodies (bi-anti-CD4, -CD8, -B220, -MAC-1, and -GR-1), which were revealed with streptavidin (SA)-allophycoerythrin (APC).
APCbright cells were removed by electronic gating. CD441CD252, CD441CD251, CD442CD251, CD442CD252 DN subsets were gated and
analyzed for green fluorescence.
(B) Thymocytes were stained with PE-anti-CD4 and CyC-anti-CD8. CD41CD81 DP, CD42CD81 SP, and CD41CD82 SP subsets were gated
and analyzed for green fluorescence.
(C) Thymocytes were stained with PE-anti-TCRgd, bi-anti-CD24 (revealed with SA-APC), and a cocktail of CyC antibodies (anti-CD4, -CD8,
and -B220). CyCbright cells were removed by electronic gating. TCRgd1HSAhi, TCRgd1HSAlo, TCRgd2HSAhi, and TCRgd2HSAlo subsets were
gated and analyzed for green fluorescence.
(D) Thymocytes were stained as in (A). CD442CD251 cells were gated and analyzed by forward scatter for small resting (SR) and large cycling
(LC) subsets, which were assessed for green fluorescence.
used the Cre-loxP strategy (Gu et al., 1993) to isolate heterozygous RAG21/GFP, and wild-type RAG21/1 mice
for analysis (Figure 1C).cells with Cre-mediated deletions of the PGK-neor gene
(Figure 1B). These cells (RAG21/GFP) contain a single loxP
site 400 bp downstream of the RAG2 39 UTR on the RAG2:GFP Supports Normal V(D)J Recombination
and Lymphocyte DevelopmentRAG2:GFP±replaced allele. We used RAG21/GFP ES cells
to generate chimeras that were then bred to 129SvEv As a preliminary test of the ability of the RAG2:GFP
fusion protein to support V(D)J recombination, we tran-mice to obtain germline transmission of the RAG2:GFP
gene. The heterozygous RAG21/GFP offspring were sub- siently transfected a pCMV-RAG2:GFP expression con-
struct, a RAG1 expression construct, and the pJH200sequently crossed to generate homozygous RAG2GFP/GFP,
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Figure 3. Expression of RAG2:GFP in Developing B Cells
(A and B) FACS analysis was performed on BM cells from RAG21/1 (WT) and RAG2GFP/GFP (RAG2:GFP) mice after staining with CyC-anti-B220
and either PE-anti-CD43, -IgM, -c-kit, or -CD25. Freshly isolated BM was used for all analyses except c-kit 3 B220, which was performed on
BM cultured on the T220 stromal line for 1±2 weeks to enrich for c-kit1 cells. A representative FACS plot is shown for each set of markers,
as there were no significant differences in phenotype between WT and RAG2:GFP BM. For each of the gated populations in (A), histograms
for green fluorescence were generated; gated populations in (B) were analyzed by forward scatter for small resting (SR) and large cycling
(LC) subsets, which were subsequently assessed for green fluorescence. WT histograms (shaded) were overlayed with RAG2:GFP histograms
(open); percentages of cells out of total live lymphocytes are shown for each population (top, WT; bottom, RAG2:GFP).
recombination substrate into CHO fibroblasts. In this and late (CD442CD252) stage DN thymocytes but is
expressed in the intermediate CD441CD251 andassay, the RAG2:GFP protein promoted V(D)J recombi-
nation at levels comparable to wild-type RAG2 and did CD442CD251 subsets, the latter of which is character-
ized by the onset of TCRb, g, and d rearrangementsnot interfere with wild-type RAG2 function when in-
cluded in the same transfection (data not shown). In (Figure 2A). Furthermore, we observed that RAG2:GFP
expression is downregulated between small restingaddition, lymphocyte development in RAG2:GFP hetero-
zygous and homozygous knockin mice appeared nor- CD442CD251 and large cycling CD442CD251 cells, con-
sistent with the proposed point of TCRb selection (Fig-mal, both with respect to developing populations as
defined by surface marker expression and with respect ure 2D; Hoffman et al., 1996). Analysis of DP and SP
thymocyte subsets, as defined by CD4 and CD8 expres-to total thymocyte and splenocyte numbers (see below).
sion, also demonstrated a normal developmental pat-
tern for RAG2:GFP homozygotes (Figure 2B). RAG2:GFPRegulated RAG2:GFP Expression
in Developing Thymocytes was highly expressed in CD41CD81 DP thymocytes,
which undergo TCRa gene rearrangements, but was notBased on CD44 and CD25 expression, RAG2:GFP homo-
zygotes demonstrated a distribution of DN thymocyte sub- expressed in CD41CD82 and CD42CD81 SP subsets
(Figure 2B). Overall, RAG2:GFP expression in devel-sets similar to that of wild-type mice (Figure 2A). Histo-
gram analyses of green fluorescence demonstrated oping T cells faithfully recapitulates the developmentally
regulated expression pattern of RAG2 in thymocytesthat RAG2:GFP is not expressed in early (CD441CD252)
RAG2 Expression in RAG2:GFP Knockin Mice
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Figure 4. RAG2:GFP Is Expressed in a Small Population of Splenic B Cells
(A) Splenic cells from 4-week-old RAG21/1 (WT4wk) and RAG2GFP/GFP (RAG2:GFP4wk) and 12-week-old RAG2GFP/GFP mice were stained with CyC-
anti-B220 and analyzed by FACS. The percentages of cells in the indicated B220lo/GFP1 gate are shown. Histograms for green fluorescence
were generated for each spleen and overlayed as depicted (13 and 103 views). GFP1 cells in the RAG2:GFP4wk spleen are visible as a shoulder
in the 103 view, in comparison to the WT4wk and RAG2:GFP12wk spleens.
(B and C) FACS analysis was performed on splenic cells from WT4wk and RAG2:GFP4wk mice after staining with CyC-anti-B220 and either PE-
anti-CD25, PE-anti-IgM, PE-anti-CD43, PE-anti-CD24, or bi-493 (mAb against pB130-140Ðrevealed with SA-PE). A representative FACS plot
is shown for each set of markers, as there were no significant differences in phenotype between WT and RAG2:GFP spleen. For each of the
gated populations (depicted by schematics for [C]), histograms for green fluorescence were generated. WT histograms (shaded) were overlayed
with RAG2:GFP histograms (open); percentages of cells out of total live lymphocytes are shown for each population (top, WT; bottom,
RAG2:GFP).
previously documented (Turka et al., 1991; Guy-Grand subset composed of mature, recirculating B cells. Analy-
sis of RAG2:GFP expression in BM populations definedet al., 1992; Wilson et al., 1994; Ismaili et al., 1996),
strongly indicating that the fusion protein is expressed by IgM and B220 showed that RAG2:GFP was expressed
in most cells of both the IgM2B220lo and IgM1B220loand degraded similarly to wild-type RAG2.
We also analyzed the expression of RAG2:GFP in gd populations (Figure 3A). In addition, RAG2:GFP expres-
sion appeared inversely correlated with sIgM levels in BMthymocyte subsets. HSAhi gd1 thymocytes have been
classified as immature and were reported to express B lineage cells, with green fluorescence intensity decreas-
ing with increasing sIgM density. Although the majority ofRAG2 mRNA, while HSAlo gd1 thymocytes have been
classified as mature and lacking RAG expression (Tat- IgMhiB220lo cells had no detectable RAG2:GFP, we did
observe a subpopulation of IgMhiB220lo cells with verysumi et al., 1993). In contrast, we did not find RAG2:GFP
expression in either of these gd thymocyte populations low RAG2:GFP levels (Figure 3A).
In additional analyses, we observed that cells of(Figure 2C). We did observe RAG2:GFP expression in
HSAhi gd2 thymocytes, consistent with the expression both the c-kit1CD252 pre-B-I and c-kit2CD251 pre-B-II
stages (Rolink et al., 1994) expressed RAG2:GFP (Figureof HSA in actively rearranging DN thymocyte subsets.
3B). In both the pre-B-I and pre-B-II stages, RAG2:GFP
was highly expressed in the small resting but not theRegulated RAG2:GFP Expression in Developing
large cycling cells (Figure 3B), similar to the documentedBM B cells
pattern of RAG2 protein expression in these populationsB cell development in RAG2:GFP homozygous mice was
(Grawunder et al., 1995). RAG2:GFP expression in thesenormal, as determined by FACS analysis of surface ex-
subsets was identical whether analyzed in freshly iso-pression of CD43, IgM, and B220 (Figure 3A). Further-
lated BM samples or in BM cultures differentiated onmore, histogram analysis of the developmental subsets
the T220 stromal cell line. Our finding that RAG2:GFPdefined by these markers demonstrated that RAG2:GFP
expression faithfully reflects RAG2 protein expressionexpression closely parallels previously reported RAG
in small and large pre-B-I and pre-B-II cells, in additionexpression patterns (Figure 3A; Li et al., 1993; Gra-
to small and large CD442CD251 thymocytes, stronglywunder et al., 1995). A high level of RAG2:GFP expres-
suggests that the RAG2:GFP fusion protein is properlysion was found in CD43hi pro±B cells, while a slightly
regulated during the cell cycle and targeted for degrada-lower level was found in CD43lo pre±B cells. RAG2:GFP
expression was not detectable in the B220hiCD432 BM tion as cells exit G1 (Lin and Desiderio, 1994).
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RAG2:GFP Is Expressed in a Small Population
of Splenic B Cells in Young Mice
We examined expression of RAG2:GFP in splenic B and
T cells to search for RAG-expressing B or T cells pre-
viously reported to be in the periphery (Han et al., 1997a;
Papavasiliou et al., 1997; Hikida et al., 1998; McMahan
and Fink, 1998). While we have not detected RAG2:GFP
expression in peripheral T lineage cells, we have repro-
ducibly identified a population of RAG2:GFP1, B2201
cells in the spleens of young mice; this population de-
creases in size with age and is not detectable after 8±10
weeks (Figure 4). These cells, which represent approxi-
mately 2%±3% of total splenic lymphocytes in 4-week-
old RAG2:GFP mice, are readily apparent as a population
of B220lo cells (Figure 4A). We also have used antibodies
against several other cell-surface markers to further
characterize this population of GFP1 B cells (Figures 4B
and 4C). The majority are IgM2B220lo, although a few
can be detected in the IgMloB220lo subset. In addition,
while there are small numbers of GFP1 cells that are
CD43hi, most are CD43lo. Analyses of splenic B cell popu-
Figure 5. Expression of RAG2:GFP Is Downregulated in Splenic
lations defined by CD25, HSA, and pB130±140 demon- Transitional B Cells
strate that most of the GFP1 cells are CD251, HSAhi,
(A) Four fractions (R1±R4) of splenic B cells from RAG21/GFP and
and pB130±1401/hi. From this extensive FACS analysis, RAG21/1 mice were sorted based on surface expression of B220
we conclude that the vast majority of the GFP1 cells in and IgM. Histogram overlays depict the relative levels of green fluo-
rescence in RAG21/1 (shaded) versus RAG21/GFP (open) fractions.the spleen are phenotypically identical to the pre±B and
The indicated percentages of RAG21/GFP cells in each fraction areimmature B cells observed in the BM of RAG2:GFP mice,
calculated out of total live B2201 lymphocytes. Purity of all sortedwith an additional small fraction of GFP1 cells resem-
fractions was $95% as assessed by FACS reanalysis.bling pro±B cells.
(B) RNA was purified from sorted RAG21/GFP fractions R1±R4 and
used for RT-PCR analysis of RAG1, RAG2, and l5 mRNA expression.
b-actin was used as a control to ensure equivalent amounts of
mRNA. Equivalent results were obtained from sorted RAG21/1 frac-RAG2:GFP Is Not Detectably Expressed in Splenic
tions (data not shown).Transitional B Cells
(C) Serial 5-fold dilutions of fraction R1 cDNA were made and usedWhen we compare RAG2:GFP expression in similar pop-
for RT-PCR analysis of RAG1 and RAG2 mRNA expression in parallelulations of BM and splenic sIgM1B220lo B cells, we ob-
with undiluted R1±R4 cDNA. b-actin was used as a control to ensure
serve that expression is significantly reduced in the equivalent amounts of mRNA.
splenic fractions versus BM fractions (compare panels
in Figures 3A and 4C). As discussed above, most splenic
GFP1 B220lo cells are sIgM2, with a few having low levels RAG2:GFP Is Expressed in a Subset of Splenic B
of sIgM; we find no evidence of RAG2:GFP expression Cells following Immunization
in sIgMhiB220lo or ªtransitionalº B cells. To confirm that To determine whether RAG2:GFP±expressing cells could
RAG2:GFP reporter expression in these cells truly re- be found in the spleens of older mice following immuni-
flected downregulation of RAG gene expression, we zation, we immunized 10- to 12-week-old RAG2:GFP
performed RT-PCR on sorted B220lo populations of (RAG2GFP/GFP) and wild-type 129SvEv mice with chicken
splenic B cells isolated from wild-type and RAG2:GFP g-globulin substituted with the (4-hydroxy-3-nitrophe-
(RAG21/GFP) mice (Figure 5A). nyl)acetyl hapten (NP-CGG). Subsequently, we analyzed
In accord with our FACS analyses, we find a high the mice for the presence of splenic GFP1 cells at days
level of RAG1 and RAG2 expression, along with l5, in 8 and 16 following immunization in comparison with
IgM2B220lo fractions, a very low level of RAG expression unimmunized (naive) littermates. Naive RAG2:GFP mice
in IgMloB220lo cells, and negligible levels in IgMhiB220lo did not have detectable GFP1 splenic B cells. Strikingly,
fractions (Figure 5B). Specifically, levels of RAG1 and at day 16, but not day 8, following immunization, we
RAG2 transcripts are reduced z25-fold or more in the observed a significant population of splenic GFP1 B cells.
sIgMlo and z100-fold or more in the sIgMhi fractions as These cells, like the GFP1 cells in young RAG2:GFP mice
compared to levels in the sIgM2B220lo fraction (Figure (Figure 4A), are readily apparent as a population of
5C). The very low±level RAG expression in the sIgMhi B220lo cells (Figure 6A). In addition, these GFP1 cells
fraction might reflect low-level RAG expression in many express little or no sIgM and have uniformly high levels
of these cells or, more likely, the presence of a few cells of the immature B cell marker pB130±140 (Figure 6B).
that express high RAG levels, possibly as a result of a The B220lo/pB130±1401 population enriched for GFP1
small number of contaminating sIgM2/lo cells. In either cells was not present in spleens of naive mice or those
case, we conclude that splenic transitional B cells do analyzed at day 8 following immunization. In previous
not express appreciable RAG levels and that the RAG reports, RAG expression has been documented in a
expression in the splenic B cell compartment is derived population of splenic B cells identified by the GL-7
marker (Han et al., 1997a). We find that of the B220lo/primarily from pre±B/immature B cells.
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Figure 6. RAG2:GFP Is Expressed in a Subset of Splenic B Cells following Immunization
(A) Splenic cells from naive RAG21/1 (WT) and RAG2GFP/GFP (RAG2:GFP) mice and from RAG21/1 and RAG2GFP/GFP mice at 8 and 16 days after
immunization with NP-CGG (ªday 8º and ªday 16º) were stained with PE-anti-B220 and analyzed by FACS for expression of RAG2:GFP. The
percentages of cells in the indicated B220lo/GFP1 gate are shown. Several 10- to 12-week-old mice of each phenotype were analyzed at day
8 and day 16 in comparison with naive littermates. Data shown are from representative mice.
(B) Splenic cells from naive and immunized RAG21/1 and RAG2GFP/GFP mice were stained with PE-anti-B220 and bi-493, PE-anti-B220 and bi-
GL-7, or PE-anti-IgM and bi-GL-7 and analyzed by FACS (bi-antibodies revealed with SA-Red613). A representative FACS plot is shown for
analysis of splenic cells from naive, day 8, and day 16 mice for each set of markers, as there were no significant differences in phenotype
between RAG21/1 and RAG2GFP/GFP naive or immunized spleens. For each of the gated populations from day 16 spleen (depicted by schematics),
histograms for green fluorescence were generated. WT day 16 histograms (shaded) were overlayed with RAG2:GFP day 16 histograms (open);
percentages of cells out of total live lymphocytes are shown for each population (top, WT; bottom, RAG2:GFP).
(C) Splenic cells from day 16 RAG21/1 mice were triple stained with PE-anti-B220, bi-493, and FITC-GL-7 or with FITC-anti-B220, bi-493, and
PE-anti-IgM and analyzed by FACS. The population of pB130-140hiB220lo cells was gated for each sample and reanalyzed for the expression
of GL-7 and IgM. The percentages of GL-7bright versus GL-7dull and IgM2/lo versus IgM1 cells in the gated pB130-140hiB220lo population are
indicated.
pB130±1401 cells, approximately one-fourth of the cells much larger number of RAG-expressing cells are pres-
ent in the spleen during the late stages of an immuneare GL-71 and three-fourths are GL-72 (Figure 6C).
RAG2:GFP expression is found in both the GL-71 and response than was previously appreciated.
GL-72 subsets (Figure 6B). Thus, we have identified a
novel population of RAG-expressing cells that appears
in the spleen during the late stages of an immune re- Increased RAG2:GFP Levels following BCR
Cross-Linking of In Vitro±Generatedsponse.
The RAG2:GFP1 splenic B cells that appeared at day sIgM1sIgD1 BM Cells
Given our finding of large numbers of RAG2:GFP116 following immunization constituted a remarkable
fraction of total B2201 cells, ranging from 2%±20%, splenic B cells following immunization and recent re-
ports of RAG reinduction in peripheral sIg1 cells, wedepending on the mouse. Such a large population of
phenotypically immature B cells in the spleen following sought to test whether RAG2:GFP expression could be
reinduced in sIg1, RAG2:GFP2 cells. First, we assayedimmunization was unexpected. Furthermore, these cells
clearly express the RAG2:GFP marker, implying that a RAG2GFP/GFP spleen cells treated with LPS and IL-4, but
Immunity
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Figure 7. RAG2:GFP Expression in Cultured sIgD1 B Cells
(A) BM isolated from RAG2GFP/GFP and RAG21/1 mice was plated on the T220 stromal line for 1±2 weeks. Cells were stained with PE-anti-IgM
and bi-anti-IgD (revealed by SA-CyC) and analyzed by FACS. Histograms for green fluorescence were generated for gated populations 1±4;
WT histograms (shaded) were overlayed with RAG2:GFP histograms (open).
(B) RAG2GFP/GFP and RAG21/1 BM cells were removed from the T220 stromal line and cultured for 48 hr in medium alone (control) or medium
with 2 mg/ml F(ab9)2 anti-IgM. Cells were then stained with PE-anti-IgD and CyC-anti-B220 and analyzed by FACS. Histograms for green
fluorescence were generated for gated IgD2B2201 (1) and IgD1B2201 (2) populations. WT histograms (shaded) were overlayed with RAG2:GFP
histograms (open).
the large blasting nature of these stimulated cells obvi- of the cell cycle both in the presence or absence of BCR
ligation (data not shown).ated fluorescent marker detection (data not shown). As
another assay, we treated splenic RAG2GFP/GFP B cells with
anti-IgM. We found no clear-cut increase in RAG2:GFP Discussion
expression (data not shown), although we could have
missed induction if it occurred in a small subpopulation A Model System for Studying RAG Expression
during B and T Cell Developmentof cells.
Based on previous studies (Melamed et al., 1998), we To assess definitively RAG gene expression in individual
cells and cell populations in primary and peripheralalso assayed RAG2GFP/GFP B cells generated in vitro via
culture of BM progenitors on the T220 stromal line. In lymphoid tissues of mice, we developed a knockin strat-
egy to introduce a RAG2:GFP fusion gene into the en-these BM cultures, as in freshly isolated BM, RAG2:GFP
expression was detectable in pro±B, pre±B, and immature dogenous RAG2 locus. Our goal was to generate a GFP
reporter gene that accurately reflected endogenousB cell subsets but not in sIgMhisIgD1 cells (Figure 7A).
Addition of anti-IgM (2 mg/ml for 48 hr) to the cultures led RAG2 locus expression. Therefore, the targeting strat-
egy placed the RAG2:GFP gene under the control ofto sIgM downregulation, such that we could no longer
distinguish pre±B from previously sIgM1 immature B endogenous RAG2 regulatory elements and generated a
fusion protein that preserved RAG2 degradation signals.cells. However, following treatment (in the presence or
absence of T220 cells), the majority of the sIg2 cells con- As discussed below, RAG2:GFP developmental expres-
sion patterns precisely mimic those of endogenoustinued to express RAG2:GFP, and surviving sIgD1 cells
expressed significantly increased levels of RAG2:GFP RAG2; in addition, the RAG:GFP fusion protein mediates
V(D)J recombination and normal lymphocyte develop-compared to those of unstimulated sIgD1 cells (Figure
7B). As the anti-IgM treatment also resulted in a signifi- ment in a manner indistinguishable from the authentic
RAG2 protein.cant loss of B22Ohi/sIgDhi cells, we considered the possi-
bility that the apparent induction actually resulted from RAG2:GFP expression first appears at the early B and
T cell stages in which RAG expression has been de-cellular selection. However, labeling studies with the
fluorescent marker CFSE showed little or no division of scribed (Rodewald and Fehling, 1998; Melchers and Rol-
ink, 1999). In T cells, RAG2:GFP expression is downregu-sIgD1 cells during the course of this analysis (K. S.,
preliminary data), and most cells were in the G1 phase lated following TCRb, g, and d gene rearrangement and
RAG2 Expression in RAG2:GFP Knockin Mice
209
b selection, upregulated at the onset of TCRa gene re- Induction of Splenic RAG2:GFP1 B Cells
by Immunizationarrangement in DP thymocytes, and finally downregu-
lated again in SP thymocytes. In B cells, RAG2:GFP Our finding of a large number of RAG2:GFP1 cells in
spleens of immunized mice during the late stages ofexpression is downregulated in pro±B cells following
IgH chain assembly and expression, upregulated in an immune response confirms and extends previous
observations of RAG expression in GC B cells. We havepre±B cells coincident with the onset of IgL chain gene
rearrangement, maintained at reduced levels in many shown that the GFP1 cells are uniformly IgM2 or IgMlo,
B220lo, and pB130±140hi and thus phenotypically veryimmature sIgM1 B cells, and finally downregulated in
sIgMhi transitional B cells (see below). In both B and T similar to the GFP1 B cells in the spleens of young
mice. As previously suggested, this population of RAG-cells, RAG2:GFP expression is tightly regulated between
these developmental transitions (e.g., between DP and expressing cells arising following immunization might
be derived from more mature splenic B cells that haveSP thymocyte stages). Furthermore, RAG2:GFP fusion
protein levels, like those of wild-type RAG2, are down- downregulated expression of sIgM and B220, reaquired
expression of immature markers such as pB130±140,regulated between small resting and large cycling cells
of a given population. and reexpressed surrogate L chain and RAG genes (Han
et al., 1997a). Alternatively, the splenic GFP1 cells ob-We conclude that the RAG2:GFP marker is a faithful
indicator of RAG2 expression. Therefore, the RAG2:GFP served following immunization might represent pre±B/
immature B cells generated within residual hematopoi-knockin mice allow RAG2 expression to be assayed in
lymphocyte populations through simple FACS analyses etic islands in the spleen or that prematurely exit the
BM, as we have suggested for the GFP1 splenic B lin-and electronic gating and obviate more cumbersome
and often less informative approaches such as exten- eage cells found in young RAG2:GFP mice. Potentially,
our ability to subdivide these RAG-expressing, splenicsive cell sorting coupled with RNA and protein analyses.
Moreover, this novel model permits more quantitative pre-B-like cells into two populations based on expres-
sion of the pre±B/GC marker GL-7 may reflect differ-judgments with respect to cell numbers and relative
expression levels in given populations than are possible ences in origin and/or function.
Our current studies do not distinguish between thethrough traditional sorting strategies.
various models for the generation of RAG-expressing
splenic B cells following immunization. The model that
RAG-expressing cells are derived from mature splenicRAG2:GFP Mice Allow Definition of a Population
of RAG-Expressing Splenic B Cells B cells implies a remarkable reversal of B cell develop-
ment in the germinal center (Han et al., 1996). However,We have identified a population of RAG2:GFP±expressing
splenic B cells in young mice that closely resembles the the model that BM-derived pre±B cells potentially can be
recruited in large numbers to join an immune response inpre±B and immature B cell populations seen in BM. By
sorting these cells and equivalent populations from wild- the spleen would also represent a completely unde-
scribed phenomenon in B cell development. In this re-type mice, we confirmed that RAG2:GFP expression cor-
relates with both RAG1 and RAG2 RNA expression. This gard, injection of certain exogenous agents into mice,
such as sheep red blood cells, mineral oil, or BSA, canpopulation of RAG-expressing cells, representing ap-
proximately 2%±3% of total splenic lymphocytes at 4 increase production of BM B cells (FuÈ lop and Osmond,
1983), although it is not known whether immunizationweeks of age, decreases steadily in size through 8±10
weeks of age, at which point it is no longer detectable with various antigen/adjuvant preparations such as NP-
CGG/alum leads to a similar upregulation of BM B cellby FACS. As the spleen is a site of significant hema-
topoeisis around birth and as pre±B cells can be cloned production. The more interesting possibility is that the
recruitment of pre±B/immature B cells to the spleenfrom the spleen through 4 weeks of age (Rolink et al.,
1993), many of these RAG-expressing splenic B cells in evolved to contribute to some aspect of the immune
response, such as permitting positive selection of pre±Byoung mice could have originated from residual splenic
cells in the germinal center via the pre±B cell receptor.B cell lymphopoeisis.
Some splenic RAG-expressing cells may also be de-
rived from the BM, which becomes the major site of B RAG2:GFP Expression Decreases with Increasing
cell development after birth. As the numbers of small Density of sIgM and Is Not Detectable
pre-B-II and immature B cells in the BM peak at 4±5 in the Transitional B Cell Compartment
weeks (Melchers and Rolink, 1999), it is possible that in the Spleen
some of these cells prematurely leave the BM and take We have shown that RAG2:GFP expression in sIgM1
up residence in the spleen before it has been completely B220lo immature B cells in the BM correlates inversely
filled with more mature B and T cells. Previous studies with increasing sIgM density and is very low or absent
in our laboratory have established a precedent for the in the IgMhiB220lo subset. In the spleen, we have demon-
transit of RAG-expressing pre-B-like cells from the BM strated through FACS analysis and RT-PCR that RAG
to the spleen (Young et al., 1997; Shaw et al., 1999). The expression is very low or absent in sIgMloB220lo cells and
finding of significant numbers of splenic pre±B cells essentially absent in sIgMhiB220lo cells. This difference in
implies a potential role during normal B cell develop- RAG expression between phenotypically similar cells
ment. For example, it is possible that the continued in the BM and the spleen strongly suggests that RAG
presence of pre±B and immature B cells in the spleen expression is downregulated in these cells as they leave
might permit receptor editing in these cells that could the BM. This downregulation may be due to the loss of
eliminate B cell receptors specific for peripheral self- a tonic signal provided by the BM microenvironment
(Sandel and Monroe, 1999).antigens.
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ES clones in which the RAG2:GFP(PGK-neor) fusion gene hadFrom a pool of 2 3 107 immature BM B cells generated
replaced the endogenous RAG2 coding exon on one alleleeach day, only 10%±20% get selected into the long-
[RAG21/GFP(Neo1)] were identified by Southern blotting using the 59 probelived peripheral B cell pool (Allman et al., 1992). The site
(1.0 kb ClaI±XbaI fragment) on EcoRI-digested DNA and confirmed
where most developing B cells are lost is not clearly using the 39 probe (330 bp BglII±BamHI fragment) on EcoRI-digested
established (Pillai, 1999). However, several studies sug- DNA. RAG21/GFP(Neo1) ES cells were transiently transfected with 30
mg of pMC-CreN; clones were isolated and screened by Southerngested that transitional B cells, rather than immature B
blotting (EcoRI digest/39 probe) for deletion of the PGK-neor gene.cells, are the major target of negative selection (Carsetti
RAG2:GFP±targeted and PGK-neor-deleted TC1 ES cells (RAG21/GFP)et al., 1995; Melamed et al., 1998). These studies have
were used to generate chimeric mice by RAG22/2 blastocyst com-led to a set of related models that predict that antigen
plementation as described (Chen et al., 1993). Male chimeras were
receptor signaling leads to distinct outcomes in imma- bred to 129SvEv females to maintain a pure genetic background.
ture versus transitional B cells. In response to self-anti- Heterozygous RAG21/GFP offspring were bred to generate RAG21/1,
RAG21/GFP, and RAG2GFP/GFP mice. Genomic DNA isolation and South-gen, immature B cells are proposed to undergo receptor
ern blotting were carried out as described (Gorman et al., 1996).editing, while transitional B cells are predicted to un-
dergo apoptosis. Our finding that RAG:GFP expression
Flow Cytometryis present in immature BM B cells but undetectable in
Single-cell suspensions were stained with FITC-, PE-, CyC- andtransitional B cells in the spleen is consistent with these
biotin-conjugated (bi) antibodies and analyzed by a FACSCalibur
models. (Becton-Dickinson). The following antibodies were used (Phar-
Mingen and Southern Biotechnology Associates): FITC-anti-B220
(RA3-6B2); PE-anti-CD24 (M1/69), -CD25 (PC61), -CD4 (RM4-5),Can RAG Genes Be Reexpressed in Peripheral
-TCRgd (GL3), -CD43 (S7), -IgMa (Igh-6a), -c-kit (2B8), -B220 (RA3-B Cells?
6B2), -IgD (11-26); CyC-anti-CD44 (IM7), -CD4 (RM4-5), -CD8 (53-Our analyses of the RAG2:GFP mice have led us to
6.7), -B220 (RA3-6B2); bi-anti-CD4 (RM4-5), -CD8 (53-6.7), -B220conclude that the vast majority of immature B cells
(RA3-6B2), -MAC-1 (M1/70), -GR-1 (RB6-8C5), -IgDa (Igh-5a/Igh-5.4).
downregulate RAG expression as they leave the bone FITC- and bi-GL-7 (prepared by authors) and bi-493 (provided by
marrow and enter the splenic transitional B cell compart- M. Carroll) were also used. SA-PE, -CyC, -APC, and -Red613 were
used to reveal bi-antibodies. For most FACS plots, $100,000 eventsment. However, work of others raised the general pos-
were collected; dead cells were excluded by size and forward scattersiblity that RAG genes could be reexpressed in periph-
gating. Data was analyzed with CellQuest (Becton Dickinson) oreral B cells (Han et al., 1997a; Papavasiliou et al., 1997;
FlowJo (Tree Star) software. Cell sorting was performed on a MoFloHikida et al., 1998) and, more specifically, that a subset
machine (Cytomation).
of transitional B cells retains the capacity to upregulate
RAG genes when stimulated via their BCR in the pres- RT-PCR Analysis
ence of BM (Sandel and Monroe, 1999). In this regard, Total RNA from sorted splenic populations was isolated using TRIzol
(GIBCO-BRL). RNA samples were treated with DNase I AG (GIBCO-we found that anti-IgM treatment of in vitro±differentiated
BRL), and reverse transcription of 0.5 mg of RNA was performed withBM B cell cultures led to the appearance of IgD1 cells
SUPERSCRIPT II according to the directions of the manufacturerthat expressed RAG2:GFP. While the precise mechanisms
(GIBCO-BRL). PCR reactions (25 ml) contained 2% (or serial 5-fold
of this apparent induction remain to be determined, our dilutions) of the cDNA preparations, 3 pmol of both sense and anti-
current results validate the use of the RAG2:GFP system sense oligonucleotide primer, 0.2 mM of each dNTP, 2 mM MgCl2,
to assess capacity of in vivo B lineage populations to and 1 U Taq DNA polymerase in 13 PCR buffer (QIAGEN). Intron
spanning primers for RAG1, RAG2, l5, and b-actin were as de-modulate RAG gene expression in response to various
scribed (Li et al., 1993) except that the l5 sense primer wasstimuli.
59-CTTGAGGGTCAATGAAGCTCAGA-39. Amplification was per-
formed on a GeneAmp 9600 thermocycler (Perkin-Elmer) employingExperimental Procedures
the following conditions: 3 min at 948C; 27 (b-actin) or 35 cycles of
45 s at 948C, 90 s at 608C, and 150 s at 728C; and 10 min at 728C.Construction of the RAG2:GFP Fusion Gene
PCR products were resolved on 2% agarose gels, transferred toand Targeting Vector
Zeta-Probe GT membranes (BioRad), and probed with 32P-labeledA genomic clone containing the murine RAG2 coding exon and
cDNA for l5 or with cloned PCR fragments for RAG1, RAG2, andseveral kilobases of 59 and 39 sequences was obtained. The
b-actin. Membranes were analyzed using a Storm 860 PhosphorIm-RAG2:GFP fusion gene was generated by inserting a 2.2 kb SalI±AseI
ager and ImageQuant software (Molecular Dynamics).fragment containing the RAG2 coding exon into the SacI site of
the Clontech pEGFP-N1 vector (pRAG2:GFP #1). The junction was
Immunizationssequenced to confirm that the RAG2:GFP fusion was in-frame.
RAG21/1 and RAG2G/G mice (10±12 weeks old) were immunized intra-pRAG2:GFP #1 was used in V(D)J recombination assays (data not
peritoneally with 100 mg of NP-CGG precipitated in alum as de-shown) as described (Frank et al., 1998). A 750 bp AseI±KpnI frag-
scribed (Han et al., 1997a). Spleens were taken at times indicatedment containing the z330 bp 39 UTR of RAG2 was cloned into the
after immunization and dissociated into single-cell suspensions forNotI site of pRAG2:GFP #1 located just 39 of the RAG2:GFP fusion
FACS analysis.gene to generate pRAG2:GFP #2. A 3.0 kb ClaI±SalI fragment con-
taining the genomic region 59 of the RAG2 coding exon was cloned
BM Culturesinto the BglII site of pRAG2:GFP #2 to generate pRAG2:GFP #3.
BM was plated on T220 stromal cells, an IL-7-secreting cell line,The RAG2:GFP knockin construct was generated by cloning a 5.8
and cultured for a period of 1±2 weeks. For cross-linking experi-kb XbaI fragment (containing the RAG2:GFP fusion gene and 2.2
ments, cells were harvested and plated at z1 3 106 cells/ml inkb of 59 sequences) from pRAG2:GFP #3 and a 2.4 kb KpnI±NotI
medium 6 2 mg/ml F(ab9)2 anti-mouse IgM m (Rockland) for 48 hr.fragment (containing sequences 39 of RAG2) into unique cloning
sites in the pLNTK vector (Gorman et al., 1996).
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